Date

Starts: 12.06.2023 at 10:30
Ends: 12.06.2023 at 11:30

Location

Seminar, online

Organised by

• European Patent Office
• European IP Helpdesk

Working language(s)

English

Description

This event is jointly organised by the EPO’s Patent Academy and the European Intellectual Property (IP) Helpdesk to showcase successful technology transfer journeys in the fight against cancer. 

According to estimates from the World Health Organization (WHO), cancer is one of the leading causes of death before the age of 70 years in over 100 countries. Worldwide, almost 20 million new cancer cases and almost 10 million cancer deaths occurred in 2020 alone, with the cancer burden expected to increase further in the coming decades. Thus, it comes as no surprise that the global cancer therapy market surpassed USD 150 billion in 2020 and is expected to double by the end of this decade.

Start-ups and universities play a significant role in this market since they are often the first to develop new diagnostic approaches, new drugs and therapies and work closely together to conduct research and clinical trials.

Therefore, the EPO has developed a new set of innovation case studies covering three cases in total to highlight the importance of good IP management and smart IP strategies to facilitate the exploitation and commercialisation of novel technologies to fight cancer. Based on these case studies, the subsequent seminar series aims to illustrate how patents facilitate technology transfer from R&D-conducting organisations and promote market success. 

In this session, we will hear how two scientists-turned-entrepreneurs have advanced a technology platform for immunology vaccines, enabling treatments for allergies and cancer. Based on a strong patent portfolio, they founded the company OncoQR and several other start-up companies for product development and technology commercialisation. IP was essential for attracting investment and generating licensing revenues early on to finance the long time-to-market periods that are typical in biotechnology.

Target groups

• IP authorities, patent offices, civil servants, customs officials
• Industry
• Industry researchers
• IP lawyers
• Patent information professionals
• Policy makers
• Public sector and university researchers
• SMEs and start-ups
• Business consultants and advisors
• Investors
• Technology transfer officers

Level of expertise

Intermediate

Medium

Online training

Venue details

Online

Contact

European IP Helpdesk
training@iprhelpdesk.eu

Max. number of participants

1000

Reference

BS01c-2023

Registration deadline

Deadline for registration is over.

• Online registration form